Judge seems OK with Ackman’s $290M Allergan settlement

Bill Ackman and Valeant Pharmaceuticals can breathe a sigh of relief — for now. A federal judge in California indicated Tuesday that he would grant preliminary approval to a $290 million settlement Ackman’s Pershing Square and Valeant reached with shareholders of Botox-maker Allergan. “The Court has vacated the trial date

Ackman looks to persuade judge $290M Allergan settlement is fair

Bill Ackman is going to try and hold onto a little cash on Tuesday. Lawyers for the embattled hedgie will appear before a federal judge in Los Angeles in an attempt to persuade him the $290 million settlement with Allergan shareholders is fair. Earlier this month, Judge David O. Carter

Ackman’s Pershing Square fund to slash management fee

see also Hedgie Bill Ackman on Wednesday ripped a page from a discount retailer’s playbook — he put his product on sale. Ackman’s Pershing Square fund — after posting losses in each of the past three years — said it would slash its 1.5 percent annual management fee. The discount for

Judge has questions for Ackman about proposed settlement

Just when he thought he was out, hedgie Bill Ackman is being pulled back into his disastrous Valeant Pharmaceuticals relationship by a California judge. The judge on Tuesday said that he has “substantial questions” about the $290 million settlement Ackman’s Pershing Square and Valeant proposed last week to settle

John Paulson joins Valeant’s board despite heavy losses

Billionaire John Paulson is doubling down on Valeant Pharmaceuticals. The hedge-fund tycoon said Monday he is joining the board of the scandal-ridden pharma giant — despite the fact that he’s lost nearly $2 billion on the company’s shares thus far. The move comes just three months after fellow hedgie Bill Ackman of

John Paulson joins Valeant’s board despite heavy losses

Billionaire John Paulson is doubling down on Valeant Pharmaceuticals. The hedge-fund tycoon said Monday he is joining the board of the scandal-ridden pharma giant — despite the fact that he’s lost nearly $2 billion on the company’s shares thus far. The move comes just three months after fellow hedgie Bill Ackman of

John Paulson joins Valeant’s board despite heavy losses

Billionaire John Paulson is doubling down on Valeant Pharmaceuticals. The hedge-fund tycoon said Monday he is joining the board of the scandal-ridden pharma giant — despite the fact that he’s lost nearly $2 billion on the company’s shares thus far. The move comes just three months after fellow hedgie Bill Ackman of